4//SEC Filing
Posard Matthew L. 4
Accession 0001415889-22-012142
CIK 0001159036other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 7:07 PM ET
Size
8.9 KB
Accession
0001415889-22-012142
Insider Transaction Report
Form 4
Posard Matthew L.
Director
Transactions
- Sale
Common Stock
2022-12-05$55.74/sh−10,000$557,370→ 115,189 total - Sale
Common Stock
2022-12-06$56.12/sh−10,000$561,180→ 105,189 total - Sale
Common Stock
2022-12-02$58.80/sh−10,000$588,000→ 125,189 total
Footnotes (3)
- [F1]Represents a weighted average sales price per share. The shares were sold at prices ranging from $58.80 to $58.83. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F2]Represents a weighted average sales price per share. The shares were sold at prices ranging from $55.70 to $55.83. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]Represents a weighted average sales price per share. The shares were sold at prices ranging from $56.10 to $56.19. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001543792
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 7:07 PM ET
- Size
- 8.9 KB